Dr. Andrew Marple, M.D., PH.D.
What this data tells you about Dr. Marple
Dr. Andrew Marple is a hematology & oncology in Sarasota, FL, with 10 years in practice. Based on federal Medicare data, Dr. Marple performed 281,384 Medicare services across 6,517 unique beneficiaries.
Between the years covered by Open Payments, Dr. Marple received a total of $2,269 from 30 pharmaceutical and/or device companies across 79 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Marple is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 142,800 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 30,000 | $43 | $105 |
| Daratumumab injection (Darzalex) | 23,580 | $38 | $90 |
| Anti-nausea injection (fosaprepitant) | 19,652 | $0 | $1 |
| Paclitaxel chemotherapy injection | 13,741 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 12,661 | $18 | $42 |
| Epoetin alfa injection (Retacrit) for anemia | 8,290 | $6 | $16 |
| Dexamethasone injection (steroid) | 4,785 | $0 | $2 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,290 | $1 | $34 |
| Complete blood count (CBC) with differential | 2,362 | $8 | $22 |
| Office visit, established patient (30-39 min) | 2,354 | $93 | $218 |
| Comprehensive metabolic blood panel | 2,179 | $10 | $30 |
| Blood draw (venipuncture) | 2,122 | $8 | $14 |
| Injection, leucovorin calcium, per 50 mg | 1,673 | $3 | $9 |
| Injection, fluorouracil, 500 mg | 941 | $2 | $4 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 796 | $22 | $63 |
| Administration of chemotherapy into vein, 1 hour or less | 678 | $99 | $280 |
| Ferritin level test (iron stores) | 534 | $13 | $39 |
| Iron level test | 526 | $6 | $18 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 511 | $3 | $8 |
| Drug injection, under skin or into muscle | 505 | $11 | $51 |
| Injection, carboplatin, 50 mg | 495 | $2 | $5 |
| Iron binding capacity test | 492 | $9 | $24 |
| Office visit, established patient, complex (40-54 min) | 448 | $136 | $294 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 390 | $48 | $148 |
| Injection, zoledronic acid, 1 mg | 376 | $7 | $31 |
| Vitamin B-12 level test | 342 | $15 | $43 |
| Folic acid level test | 333 | $14 | $42 |
| Office visit, established patient (20-29 min) | 312 | $61 | $150 |
| Injection, magnesium sulfate, per 500 mg | 264 | $1 | $1 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 260 | $55 | $158 |
| Administration of additional new drug or substance into vein, 1 hour or less | 221 | $49 | $139 |
| Administration of chemotherapy into vein, each additional hour | 209 | $22 | $62 |
| Microscopic examination for white blood cells with manual cell count | 208 | $4 | $10 |
| Complete blood count (CBC), automated | 208 | $6 | $18 |
| Injection of additional new drug or substance into vein | 189 | $12 | $44 |
| Infusion, normal saline solution , 1000 cc | 181 | $2 | $5 |
| Irrigation of implanted venous access drug delivery device | 171 | $18 | $55 |
| Injection, diphenhydramine hcl, up to 50 mg | 159 | $1 | $2 |
| Administration of additional new drug or substance into vein using push technique | 150 | $42 | $123 |
| Magnesium level test | 147 | $7 | $18 |
| New patient office visit (45-59 min) | 140 | $125 | $334 |
| Infusion into a vein for hydration, 31-60 minutes | 129 | $24 | $115 |
| Infusion into a vein for hydration, each additional hour | 126 | $10 | $30 |
| Uric acid level test | 123 | $4 | $13 |
| New patient office visit, complex (60-74 min) | 119 | $167 | $421 |
| Thyroid stimulating hormone (TSH) test | 116 | $16 | $48 |
| C-reactive protein test (inflammation marker) | 107 | $5 | $15 |
| Injection, prochlorperazine, up to 10 mg | 104 | $2 | $8 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 88 | $15 | $43 |
| Administration of prolonged chemotherapy into vein | 83 | $97 | $283 |
| Sed rate test (inflammation marker) | 77 | $3 | $8 |
| Urinalysis with microscopic exam | 70 | $3 | $9 |
| Initial hospital admission, high complexity | 70 | $137 | $415 |
| Hospital follow-up visit, moderate complexity | 67 | $63 | $149 |
| Hospital follow-up visit, high complexity | 67 | $93 | $213 |
| Red blood count automated, with additional calculations | 66 | $5 | $11 |
| Blood creatinine level | 54 | $5 | $15 |
| PSA test (prostate cancer screening) | 52 | $18 | $53 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 40 | $15 | $41 |
| Free thyroxine (T4) test | 32 | $9 | $25 |
| Testosterone (hormone) level, total | 30 | $25 | $71 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 30 | $1 | $3 |
| Drawing of blood for a medical problem | 21 | $66 | $201 |
| Prothrombin time test (blood clotting) | 14 | $4 | $12 |
| Lipid panel (cholesterol and triglycerides) | 12 | $12 | $38 |
| Vitamin D level test | 12 | $29 | $81 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Marple is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Marple experienced with iron infusion (feraheme)?
Does Dr. Marple receive payments from pharmaceutical companies?
How do Dr. Marple's costs compare to other hematology & oncologys in Sarasota?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology